ANIK vs OWLT
ANIK: Anika Therapeutics is a regenerative medicine company specializing in hyaluronic acid-based solutions for joint health and soft tissue repair. OWLT: Owlet is the pioneer of smart infant monitoring, providing FDA-cleared wearable technology and a digital health subscription platform for parents.
Side-by-side fundamentals
| Metric | ANIK | OWLT | Edge |
|---|---|---|---|
| Price as of 2026-10-30 close | $20.95 | $4.05 | |
| Market cap | $280M | $118M | |
| Net margin FY2025, SEC XBRL | -9.6% | -37.5% | ANIK higher |
| Gross margin FY2025, SEC XBRL | +56.6% | +50.6% | ANIK higher |
| Operating margin FY2025, SEC XBRL | -9.8% | -7.8% | OWLT higher |
| ROE FY2025, SEC XBRL | -7.6% | -208.4% | ANIK higher |
| ROA FY2025, SEC XBRL | -5.7% | -46.3% | ANIK higher |
| Debt / equity | 0.00 | 0.74 | ANIK lower |
| Revenue growth (YoY) FY2025, SEC XBRL | -5.9% | +35.4% | OWLT higher |
| Revenue CAGR (3y) SEC XBRL | -0.3% | +15.2% | OWLT higher |
| Dividend streak (yrs) SEC XBRL | 0 | 0 | Tie |
| Beta as of 2026-09-03 | 0.91 | 1.41 | |
| 1-year return as of 2026-10-30 close | +114.2% | -57.2% | ANIK higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-30.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.